Novel approaches are urgently needed to treat Diffuse intrinsic pontine glioma (DIPG) . We hypothesize that reversing signature gene expression derived from DIPG RNA-Seq samples will facilitate novel therapeutic discovery for DIPG. We therefore request the raw RNA-Seq FASTQ files to build DIPG gene expression signature which will be fed into our computational pipeline to identify potential candidates, followed by experimental validation.
Get the Latest
news, articles, and resources sent to your inbox.